Evidence map›Paper›PMID 18647409›Full record

ArticleBMC medicine2008

Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium.

M Khair Elzarrad, Abu Haroon, Klaus Willecke, Radoslaw Dobrowolski, Mark N Gillespie, Abu-Bakr Al-Mehdi

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 147 citations in OpenAlex.

  1. Article
  2. Pathology oncology research : POR · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

M Khair ElzarradDepartment of Pharmacology and Center for Lung Biology, University of South Alabama, North University Boulevard, Mobile, AL 36688, USA. mke303@jaguar1.usouthal.edu
Abu Haroon
Klaus Willecke
Radoslaw Dobrowolski
Mark N Gillespie
Abu-Bakr Al-Mehdi
University of South Alabama · USUniversity of Bonn · DE

Funding

SPECIALIZED CENTER OF RESEARCH IN HYPERBARIC OXYGEN THERP50AT000428 · NCCIH · UNIVERSITY OF PENNSYLVANIA · PI THOM, STEPHEN RAYMOND · 2000 to 2004
$7.9M
NCCIH NIH HHS P50 AT000428NCCIH NIH HHS P50 AT00428-01
6 · The paper itself

Abstract

backgroundThe modulation of gap junctional communication between tumor cells and between tumor and vascular endothelial cells during tumorigenesis and metastasis is complex. The notion of a role for loss of gap junctional intercellular communication in tumorigenesis and metastasis has been controversial. While some of the stages of tumorigenesis and metastasis, such as uncontrolled cell division and cellular detachment, would necessitate the loss of intercellular junctions, other stages, such as intravasation, endothelial attachment, and vascularization, likely require increased cell-cell contact. We hypothesized that, in this multi-stage scheme, connexin-43 is centrally involved as a cell adhesion molecule mediating metastatic tumor attachment to the pulmonary endothelium.

methodsTumor cell attachment to pulmonary vasculature, tumor growth, and connexin-43 expression was studied in metastatic lung tumor sections obtained after tail-vein injection into nude mice of syngeneic breast cancer cell lines, overexpressing wild type connexin-43 or dominant-negatively mutated connexin-43 proteins. High-resolution immunofluorescence microscopy and Western blot analysis was performed using a connexin-43 monoclonal antibody. Calcein Orange Red AM dye transfer by fluorescence imaging was used to evaluate the gap junction function.

resultsAdhesion of breast cancer cells to the pulmonary endothelium increased with cancer cells overexpressing connexin-43 and markedly decreased with cells expressing dominant-negative connexin-43. Upregulation of connexin-43 was observed in tumor cell-endothelial cell contact areas in vitro and in vivo, and in areas of intratumor blood vessels and in micrometastatic foci.

conclusionConnexin-43 facilitates metastatic 'homing' by increasing adhesion of cancer cells to the lung endothelial cells. The marked upregulation of connexin-43 in tumor cell-endothelial cell contact areas, whether in preexisting 'homing' vessels or in newly formed tumor vessels, suggests that connexin-43 can serve as a potential marker of micrometastases and tumor vasculature and that it may play a role in the early incorporation of endothelial cells into small tumors as seeds for vasculogenesis.

Indexed as

AnimalsCell AdhesionCell Line, TumorConnexin 43Endothelium, VascularFemaleGap JunctionsGene Expression Regulation, NeoplasticLungLung NeoplasmsMammary Neoplasms, ExperimentalMiceMice, NudeMutation, MissenseNeoplasms, Glandular and EpithelialNeoplasm TransplantationConnexin 43

Identifiers

PMID18647409
PMCPMC2492868
OpenAlexW2134935836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.